
北美医疗第二意见市场预测至 2027 年 - COVID-19 影响和分析 - COVID-19 影响和分析 - 按疾病分类(癌症、骨科疾病、心脏疾病、神经系统疾病、肾病、血液系统疾病、慢性阻塞性肺病、器官移植、和其他疾病)和服务提供商(医院、健康保险公司和在线服务)
No. of Pages: 100 | Report Code: TIPRE00025159 | Category: Life Sciences
No. of Pages: 100 | Report Code: TIPRE00025159 | Category: Life Sciences
医疗第二意见旨在提供有关患者当前治疗选择的有价值的信息。这一概念在处理因针对单个病例推荐各种治疗方案而造成的混乱方面发挥着重要作用。此外,还寻求该意见以获得更多信息,这有助于改善疾病的治疗结果。医学第二意见可以验证诊断;因此,它在提高治疗准确性方面发挥着重要作用。
北美医疗第二意见市场预计将从2020年的14.8014亿美元增至2027年的44.7622亿美元;预计 2020 年至 2027 年复合年增长率为 17.1%。市场的增长归因于人们越来越重视卓越的治疗结果以及越来越倾向于医疗保健成本优化。然而,全球范围内缺乏使用医疗第二意见的明确指南可能会对预测期内的市场增长产生负面影响。
越来越重视实现更好的治疗结果推动了市场增长第二医疗意见市场。许多治疗程序很可能产生不良反应,甚至可能导致死亡。因此,在关键情况下修改当前的治疗方案并寻求另一位可靠的医疗保健专业人士的建议以避免可能的不良影响变得至关重要。根据约翰·霍普金斯大学2018年发表的一项研究,美国每年约有25万人因医疗失误而死亡。如此大范围的医疗错误预计会鼓励消费者选择医疗第二意见。根据世界卫生组织的数据,2018年,全球估计有960万患者因癌症的发生而丧生。此外,吸烟、酗酒、不健康饮食和肥胖等危险因素的增加预计将进一步提高癌症的患病率。因此,癌症患病率的增加,加上寻求第二意见的癌症患者数量增加,将成为预测期内推动医疗第二意见市场的重要因素之一。由于医疗保健专业人员总体短缺和可用资源有限,医疗保健相关成本不断增加,因此需要在全球范围内优化医疗保健成本。此外,越来越重视降低额外成本并提高对医疗机构可能利用的意识,尤其是在低收入和中等收入国家,这极大地推动了医疗第二医疗意见市场的发展。
< COVID-19大流行严重影响了北美地区国家。随着病毒爆发不断蔓延,该地区必须提供针对 COVID-19 的第二意见。该地区大多数国家面临全面封锁;在这个充满挑战的时期,患者应该了解治疗方案。例如,西奈山卫生系统正在利用人工智能的力量来帮助分析美国境内 COVID-19 患者的肺部扫描结果。他们的 AI 模型的高灵敏度可以在 CT 呈阴性(在感染早期)或显示非特异性结果(这种情况很常见)的情况下为医生提供第二意见。此外,该地区政府就使用羟氯喹作为 COVID-19 的有效治疗方法征求了第二意见。因此,COVID-19 的爆发很可能将支持医疗第二意见市场的增长。
根据疾病,北美医疗第二意见市场分为癌症、糖尿病、心脏疾病、神经系统疾病、肾脏疾病、血液疾病、慢性阻塞性肺病、骨科疾病、器官移植和其他疾病。癌症细分市场在 2019 年占据最大市场份额。然而,预计骨科疾病细分市场在预测期内的复合年增长率最高。
基于服务提供商,北美医疗第二意见市场分为医院、健康保险公司和在线服务。 2019年,医院细分市场占据最大市场份额;然而,在线服务领域预计在预测期内的市场复合年增长率最高。
p>
与这份关于北美医疗第二意见市场的报告由加拿大创新基金会(CFI)、卫生和家庭福利部(MoHFW)以及美国药物研究和制造商(PhRMA)组成。
Strategic insights for North America Medical Second Opinion involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 1,480.14 Million |
Market Size by 2027 | US$ 4,476.22 Million |
Global CAGR (2020 - 2027) | 17.1% |
Historical Data | 2018-2019 |
Forecast period | 2021-2027 |
Segments Covered |
By 疾病
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Medical Second Opinion refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Medical Second Opinion Market is valued at US$ 1,480.14 Million in 2020, it is projected to reach US$ 4,476.22 Million by 2027.
As per our report North America Medical Second Opinion Market, the market size is valued at US$ 1,480.14 Million in 2020, projecting it to reach US$ 4,476.22 Million by 2027. This translates to a CAGR of approximately 17.1% during the forecast period.
The North America Medical Second Opinion Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Medical Second Opinion Market report:
The North America Medical Second Opinion Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Medical Second Opinion Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Medical Second Opinion Market value chain can benefit from the information contained in a comprehensive market report.